• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY CMW - 9610921 SMARTSET GHV GENTAMICIN 40G; BONE CEMENT : BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY CMW - 9610921 SMARTSET GHV GENTAMICIN 40G; BONE CEMENT : BONE CEMENT Back to Search Results
Model Number 5450-35-500
Device Problem Loss of or Failure to Bond (1068)
Patient Problems Edema (1820); Pain (1994); Synovitis (2094); Ambulation Difficulties (2544); Limited Mobility Of The Implanted Joint (2671); No Code Available (3191)
Event Date 02/13/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial reporter occupation: lawyer.(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Patient received a left pfc primary tka to treat pain and swelling secondary to end stage degenerative joint disease.The surgeon notes that the patient has a history of chronic pain and a history of an mcl reconstruction.The patella was resurfaced and depuy cement x 2 was utilized.The procedure was completed without complications.Patient presents s/p left tka with pain, swelling, and walking difficulty.The patient reports losing 30-40 pounds after increasing physical activity.Physical examination identifies joint crepitus and a decrease in rom in flexion and extension.X-rays indicate a tibial tray that has migrated into valgus secondary to loosening.The patient¿s symptoms and pain progressed and on (b)(6) 2018, the patient was referred for revision surgery.Patient received a left knee revision to treat pain, swelling, joint crepitus, walking difficulty, and a decrease on joint rom secondary to loosening and migration of the tibial tray.Upon entering the joint, the surgeon identified and debrided mild effusion and synovitis.The tibial tray loosened and debonded at the cement to implant interface, had subsided into valgus, and was revised.The femoral component and patella were well-fixed, stable, and retained.There was no reported product problem with the explanted tibial insert.The patient was revised with depuy revision components secured with depuy high-viscosity smartset cement.The procedure was completed without complications.Doi: (b)(6) 2015.Dor: (b)(6) 2018; left knee.
 
Manufacturer Narrative
Product complaint (b)(4).Investigation summary : no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Device history lot : device history reviewed 18 march 2020 0 non-conformances on this lot number.Final micro and sterility tests passed.(b)(4) units released.Lot expiry date: 2016-09.
 
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
Product complaint (b)(4).Investigation summary : no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Device history lot : device history reviewed (b)(6) 2020.0 non-conformances on this lot number.Final micro and sterility tests passed.(b)(4) units released.Lot expiry date: 2016-09.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTSET GHV GENTAMICIN 40G
Type of Device
BONE CEMENT : BONE CEMENT
Manufacturer (Section D)
DEPUY CMW - 9610921
cornford rd
blackpool FY4 4 QQ
UK  FY4 4QQ
Manufacturer (Section G)
DEPUY CMW - 9610921
cornford rd
blackpool FY4 4 QQ
UK   FY4 4QQ
Manufacturer Contact
kara ditty-bovard
700 orthopaedic drive
warsaw, IN 46581-0988
6107428552
MDR Report Key10385708
MDR Text Key202257247
Report Number1818910-2020-17780
Device Sequence Number1
Product Code MBB
UDI-Device Identifier10603295174288
UDI-Public10603295174288
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K033563
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 07/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2016
Device Model Number5450-35-500
Device Catalogue Number545035500
Device Lot Number7995404
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/21/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/06/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MBT CEM KEEL TIB TRAY SZ4; PFC SIGMARP STB TB IN 5 10.0; PFC*SIGMA/OV/DOME PAT 3PEG,38; SIGMA PS CEM FEM SZ5 L; SMARTSET GHV GENTAMICIN 40G; MBT CEM KEEL TIB TRAY SZ4; PFC SIGMARP STB TB IN 5 10.0; PFC*SIGMA/OV/DOME PAT 3PEG,38; SIGMA PS CEM FEM SZ5 L; SMARTSET GHV GENTAMICIN 40G
Patient Outcome(s) Required Intervention;
Patient Age61 YR
Patient SexMale
-
-